Cdc7 inhibitor 7c
CAS No. 1330781-04-8
Cdc7 inhibitor 7c ( Cdc7-IN-7c; Cdc7 IN 7c; Cdc7IN7c; Cdc7 inhibitor 7c )
Catalog No. M11315 CAS No. 1330781-04-8
A highly potent, selective and time-dependent Cdc7 kinase inhibitor with IC50 of 0.7 nM with slow dissociation property, with 200-fold and >14,000-fold selectivity over CDK2 and ROCK1, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 745 | Get Quote |
|
10MG | 1017 | Get Quote |
|
25MG | 1431 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
500MG | 4410 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCdc7 inhibitor 7c
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent, selective and time-dependent Cdc7 kinase inhibitor with IC50 of 0.7 nM with slow dissociation property, with 200-fold and >14,000-fold selectivity over CDK2 and ROCK1, respectively.
-
DescriptionA highly potent, selective and time-dependent Cdc7 kinase inhibitor with IC50 of 0.7 nM with slow dissociation property, with 200-fold and >14,000-fold selectivity over CDK2 and ROCK1, respectively; exhibits significant time-dependent Cdc7 inhibition with slow dissociation kinetics, cellular pharmacodynamic (PD) effects, and COLO205 growth inhibition.
-
SynonymsCdc7-IN-7c; Cdc7 IN 7c; Cdc7IN7c; Cdc7 inhibitor 7c
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1330781-04-8
-
Formula Weight315.40
-
Molecular FormulaC15H17N5OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C2=C(C=C(C3=CNN=C3C)S2)N=C(CN4CCCC4)N1
-
Chemical Name6-(3-methyl-1H-pyrazol-4-yl)-2-(pyrrolidin-1-ylmethyl)thieno[3,2-d]pyrimidin-4(3H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kurasawa O, et al. Bioorg Med Chem. 2017 Jul 15;25(14):3658-3670.
molnova catalog
related products
-
THZ-1 hydrochloride
THZ-1 hydrochloride is a potent, selective, covalent CDK7 inhibitor with IC50 of 3.2 nM; also weakly inhibits CDK12 with IC50 of 250 nM.
-
Amt-87
Amt-87 is a HIV latency-reversal agent that reactivates latent HIV at the transcriptional level, promotes phosphorylation of CDK9 T-loop at Thr186.
-
Ro-3306
Ro-3306 is a potent and selective inhibitor of CDK1, with Kis of 20 nM, 35 nM and 340 nM for CDK1, CDK1/cyclin B1 and CDK2/cyclin E, respectively.